Samsung Pharm Co Ltd banner
S

Samsung Pharm Co Ltd
KRX:001360

Watchlist Manager
Samsung Pharm Co Ltd
KRX:001360
Watchlist
Price: 1 991 KRW -2.88% Market Closed
Market Cap: ₩187.5B

Samsung Pharm Co Ltd
Investor Relations

SAMSUNG PHARMACEUTICAL Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. The company is headquartered in Hwaseong, Gyeonggi-Do. Co., LTD., formerly SAMSUNG PHARMACEUTICAL.CO.,Ltd., is a Korea-based company principally engaged in the manufacture and sale of pharmaceuticals. The firm operates its business through two segments. The Pharmaceutical and Quasi-drug Sale Business segment manufactures and sells prescription medicines, general pharmaceuticals and quasi-medicines. This segment's products include anticancer immunotherapy agents, antipyretic analgestic and anti-inflammatory agents, hypotensive agents, antiarteriosclerotic agents, anti-spastics, enzyme agents, ostepoposis agents, antibiotics, medicines for digestive system, medicines for liver disorder, medicines for circulation system and vitamin supplements, among others. The Health Food Manufacturing and Sale segment manufactures and sells nutrition and invigoration products.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Won-Kyu Kim
Chairman and Chief Executive Officer
No Bio Available
Byung-Eul Choi
Managing Director
No Bio Available

Contacts

Address
GYEONGGI-DO
Hwaseong
10, Jeyakgongdan 4-gil, Hyangnam-eup
Contacts
+82313536681
www.sspharm.co.kr
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett